SPARC and neoplasm: Our findings in the present study indicate that SPARC exerts a tumour-suppressor effect on OvCa cells in part through inhibiting their interactions with omental adipocytes; the main site of metastasis of OvCa [3, 42, 43], and the most common cause of mortality in OvCa patients [43].